Existing user? Login

Category list : Radiation-sensitising agents

Sort by: Newest first Oldest first A-Z Z-A

  • Caution with concomitant Zelboraf and radiation treatment Subscription

    30 NOV 2015 13:42

    The summary of product characteristics for Zelboraf (vemurafenib; Roche) now states that cases of radiation recall and radiation sensitisation have been reported in patients treated with radiation either prior, during, or subsequent to vemurafenib treatment. Therefore, vemurafenib should be used with caution when given concomitantly or sequentially with radiation treatment.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.